---
$id: https://graph.org.ai/products/commodity/51142517
$type: Product
source: UNSPSC
code: "51142517"
title: "Amantadine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Amantadine

**UNSPSC Code**: 51142517
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiviral agent and cation channel blocker with the molecular formula C10H17N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BF4C9Z1J53, chemically known as 1-aminotricyclo(3.3.1.1(sup 3,7))decane but generally known as amantadine, which bears US NIH Compound Identifier 2130. Amantadine most often comes in base and hydrochloride\tforms and is often combined with ribavirin and interferon (alpha). European Medicines Agency schedules Amantadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05389MIG. The term AMANTADINE is an International Non-Proprietary Name. World Health Organization schedules amantadine in its Anatomical Therapeutic Chemical (ATC) Classification. AMANTADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amantadine under HS 29213099 and SITC 51453. As of Q4 2014, AMANTADINE remains the US FDA Preferred Term for this commodity. Amantadine bears US NLM identifiers UMLS ID C0002403 and NCI Concept Code C61632. SMILES: C1C2CC3CC1CC(C2)(C3)N.

